Role of Apical Caspases and Glucocorticoid-Regulated Genes in Glucocorticoid- Induced Apoptosis of Pre-B Leukemic Cells1
Total Page:16
File Type:pdf, Size:1020Kb
[CANCER RESEARCH 63, 172–178, January 1, 2003] Role of Apical Caspases and Glucocorticoid-regulated Genes in Glucocorticoid- induced Apoptosis of Pre-B Leukemic Cells1 Sonia L. Planey,2 Marc T. Abrams,2 Noreen M. Robertson, and Gerald Litwack3 Department of Biochemistry and Molecular Pharmacology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 ABSTRACT two major pathways of caspase activation have been described: the receptor-mediated extrinsic pathway and the mitochondrial-mediated Glucocorticoid (GC) sensitivity in hematopoietic cells requires the ac- intrinsic pathway. Caspase-8 and caspase-10 are initiators of the tivation and nuclear translocation of the glucocorticoid receptor (GR) and extrinsic pathway where they are activated in response to death the subsequent activation of caspases. To gain insight into the caspase cascade responsible for the execution phase of GC-induced apoptosis, 697 receptor engagement by ligands belonging to the TNF superfamily pre-B leukemic cells were stably transfected with dominant negative (6). The intrinsic pathway involves mitochondrial disruption by pro- forms of caspase-8, caspase-9, or caspase-10 and the caspase-8 inhibitor apoptotic Bcl-2 family members and consequent release of factors CrmA. We observed that inhibition of caspase-9 or caspase-10 activity, such as cytochrome c that promote caspase-9 activation (7). Both but not caspase-8, caused partial resistance of 697 cells to GC-induced pathways culminate in the activation of downstream effector apoptosis. Inhibition of multiple caspases through the use of specific caspase-3, caspase-6, and caspase-7 and can cooperate to enhance peptide inhibitors had an additive effect and caused complete resistance. apoptosis through caspase-8-mediated cleavage of Bid (8). To identify GR-regulated genes upstream of caspase activation in 697 We and others have observed that GC-induced apoptosis is asso- cells, we performed DNA microarray analysis. 113 genes were identified, ciated with release of cytochrome c from the mitochondria5 (9) and which were induced or repressed at least 3-fold by GC. Surprisingly, that Bcl-2 overexpression can delay (10) or inhibit this process (11), mitogen-activated protein kinase phosphatase-1 (MKP-1), a GR-induced gene in other cell types, was repressed 3-fold and correlated with an confirming a primary role for the intrinsic pathway. To this end, induction of JNK activity. These results suggest the involvement of mito- experiments using thymocytes from knockout mice have shown an gen activated protein kinases and apical caspase-9 and caspase-10 in the absolute requirement for caspase-9 and Apaf-1 (12) in GC-induced GC-induced apoptosis of pre-B lymphocytes. apoptosis but not for caspase-3 (13), suggesting redundancy among the effector caspases. We examined the involvement of apical caspases and GR-regulated genes in the GC-induced cell death of INTRODUCTION human 697 pre-B acute lymphoblastic leukemia cells. Using a com- bination of specific caspase inhibitors and stably transfected DN GCs4 are steroid hormones that have diverse tissue-specific effects caspase genes, we demonstrate a requirement for caspase-9 and involved in homeostasis and response to stress. Almost all of the caspase-10, but not caspase-8, in GC-induced apoptosis. biological consequences of exposure to GCs are mediated through the GC-induced apoptosis can be modulated by the transfection of GR, a ligand-activated transcription factor and member of the nuclear genes that affect the activity of the GR and related cofactors (e.g., receptor superfamily (1). In its unactivated state, the GR is complexed RAP46/Bag-1; Ref. 14) as well as by genes that affect functions of the with heat shock proteins and immunophilins (2). Upon binding hor- universal apoptotic machinery (e.g., Bcl-2). However, it is still unclear mone, the GR becomes activated by the ATP-dependent release of which specific GR-regulated genes are involved in the decision stage these associated proteins, inducing a conformational change in the of GC-induced apoptosis, downstream of the GR but upstream of receptor and resulting in its translocation into the nucleus. There, it caspase activation. Using microarray technology, we have found that regulates target gene expression by (a) activating or repressing tran- MKP-1, a GR-induced gene in other tissues, was strongly repressed in scription by direct binding to GREs in the promoters of specific genes 697 cells and correlated with an increase in JNK/stress-activated or (b) repressing transcription by binding to and inhibiting the func- protein kinase activity. Thus, GC-mediated cell death in 697 cells may tion of other transcription factors such as AP-1 and nuclear factor B involve GR-dependent repression of MKP-1 and subsequent activa- (reviewed in Ref. 3). tion of the proapoptotic JNK pathway (reviewed in Ref. 15). GCs induce apoptosis in numerous cell types, including immature lymphocytes and various malignancies of lymphoid origin and thus have become one of the most common therapies for corresponding MATERIALS AND METHODS leukemias and lymphomas (4). Universally, apoptosis is mediated through the activation of caspases. These aspartate-specific cysteine Materials. Restriction enzymes and other molecular biology reagents were obtained from Promega (Madison, WI), Roche (Indianapolis, IN), or New proteases cleave specific substrates within a cell, resulting in a con- England Biolabs (Beverly, MA). Horseradish peroxidase-conjugated antibod- served series of biochemical and morphological changes (5). At least ies and enhanced chemiluminescence reagents were purchased from Amer- sham Pharmacia Biotech (Piscataway, NJ). TA and RU486 were purchased Received 8/1/02; accepted 10/31/02. from Sigma Chemical Company (St. Louis, MO). All tissue culture media and The costs of publication of this article were defrayed in part by the payment of page supplements were from Invitrogen (Carlsbad, CA). The caspase inhibitors, charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Z-LEHD-FMK and Z-DQMD-FMK, and the negative control, Z-FA-FMK, 1 Supported by NIH Research Grant AI/HL40976 (to G. L.), ALA Grant RG-034N (to were purchased from Enzyme Systems Products (Livermore, CA). All other N. M. R.), and NIH Training Grant 5T32 DK07705 (to S. L. P.). chemicals were purchased from Fisher Scientific (Pittsburgh, PA). 2 These two authors contributed equally to this work. Cell Culture and Stable Transfections. Cells (697) are a cloned human 3 To whom requests for reprints should be addressed, at Thomas Jefferson University, 233 South 10th Street, BLSB #350, Philadelphia, PA 19107. Phone: (215) 503-4634; Fax: pre-B leukemic cell line derived from childhood acute lymphoblastic leukemia, (215) 503-5393; E-mail: [email protected]. which carries the t(1;19) translocation. All cell lines were cultured with RPMI 4 The abbreviations used are: GC, glucocorticoid; GR, glucocorticoid receptor; TA, media supplemented with 10% fetal bovine serum, 2 mML-glutamine, (100 triamcinolone acetonide; DN, dominant negative; MAPK, mitogen-activated protein ki- nase; MKP-1, MAPK phosphatase-1; GRE, glucocorticoid response element; TNF, tumor necrosis factor; JNK, c-Jun N-terminal kinase; mAb, monoclonal antibody; RT-PCR, 5 S. L. Planey, A. Derfoul, A. Steplewski, N. M. Robertson, and G. Litwack. Inhibition reverse transcription-PCR; GST, glutathione S-transferase; TRAIL, TNF-related apopto- of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid sis-inducing ligand; GAPDH, glyceraldehydes-3-phosphate dehydrogenase. receptor N-terminal domain, submitted for publication. 172 Downloaded from cancerres.aacrjournals.org on September 24, 2021. © 2003 American Association for Cancer Research. GC-INDUCED APOPTOSIS IN PRE-B LEUKEMIC CELLS units/ml), and streptomycin (100 g/ml) at 37°C under 5% CO2. Exponentially One-Step RT-PCR Master Mix reagents (Applied Biosystems, Foster City, growing cells were used throughout all experiments at a concentration of CA). The 18S rRNA control primer/probe set was purchased from Applied 5 ϫ 105-1 ϫ 106 cells/ml. Biosystems, and the MKP-1 primer/probe set was purchased form Midland Mammalian expression vectors were constructed as described previously Certified Reagents (Midland, TX). The sequence of the 6-carboxyfluorescein- (16, 17). The cell lines 697-Neo and 697-CrmA, 697-Bcl-2, 697-DN- labeled MKP-1 probe is 5Ј-6FAM-CCCGGTCAGCCACCATCTGCC- caspase-8, 697-DN-caspase-9, and 697-DN-caspase-10 were generated by TAMRA. The MKP-1 primer sequences are 5Ј-CACTGCCAGCAGCATT-3Ј resuspending 1 ϫ 107 cells in serum-free RPMI containing 10 gofthe and 5Ј-CTCGATTAGTCCTCATAAGGTAAGCA-3Ј. Reactions were per- expression plasmids: pcDNA3.0/Neo; pcDNA3.0/CrmA; pcDNA3.0/Bcl-2; formed in duplicate in an ABI Prism 7900 Sequence Detection System using pcDNA3.0/DN-caspase-8; pcDNA3.0/DN-caspase-9; or pcDNA3.0/DN- the recommended cycling conditions. Data were analyzed using ABI SDS caspase-10. The cells were electroporated using a 4-mm gap cuvette at 0.22kV, software. Threshold cycle (Ct) values were determined by the software as 500 microfarads, and 27–31 ms. Cells were cultured for 18–48 h before the described previously (20). Gene expression of treated cells relative to control addition of G418 at 1 mg/ml. After selection for 4 weeks, cells were subcloned cells was quantitated using 2Ct of treated cells Ϫ Ct of control cells. In Fig. 5C, the by limiting dilution and screened by immunoblot analysis for protein expres- expression of MKP-1 in vehicle-treated cells is normalized to a value of 1. sion using an ␣-T7 mouse mAb (Novagen, Madison, WI) against the T7 JNK Activity Assay. To determine JNK activity, cells were lysed in buffer epitope tag within the expression plasmid. containing 20 mM HEPES (pH 7.5), 75 mM NaCl, 2.5 mM MgCl2, 0.1 mM Determination of Cell Number, Viability, and Caspase Activity.